Please use this identifier to cite or link to this item: http://umt-ir.umt.edu.my:8080/handle/123456789/5078
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNugraha, Edwin Setiawan-
dc.date.accessioned2017-03-30T00:33:11Z-
dc.date.available2017-03-30T00:33:11Z-
dc.date.issued2010-08-
dc.identifier.urihttp://hdl.handle.net/123456789/5078-
dc.description.abstractImmunotherapy is a relatively new cancer treatment currently being investigated intensively. The goal of the treatment is to strengthen the body's own natural ability to combat cancer by enhancing the effectiveness of the immune system. Immunotherapy is divided into three groups: immune response modifier, monoclonal antibody and cancer vaccines.en_US
dc.language.isoenen_US
dc.publisherTerengganu: Universiti Malaysia Terengganuen_US
dc.relation.ispartofseriesRC 271.I45 N8 2010;-
dc.subjectRC 271.I45 N8 2010en_US
dc.subjectNugraha, Edwin Setiawanen_US
dc.subjectTesis FST 2010en_US
dc.subjectTumors -- Immunological aspectsen_US
dc.subjectImmunotherapy -- Evaluationen_US
dc.titleMathematical models of tumor growth with immunotherapy and chemotherapyen_US
dc.typeThesisen_US
Appears in Collections:Fakulti Sains dan Teknologi

Files in This Item:
File Description SizeFormat 
RC 271 .I45 N8 2010 Abstract.pdf751.77 kBAdobe PDFView/Open
RC 271 .I45 N8 2010 FullText.pdf
  Restricted Access		10.19 MBAdobe PDFView/Open Request a copy
Show simple item record


Items in UMT-IR are protected by copyright, with all rights reserved, unless otherwise indicated.